Agenus maintains a global footprint by collaborations and partnerships with major pharmaceutical and biotechnology firms in North America, Europe and Asia. Its agreements involve analysis and enhancement collaborations, license arrangements and co-growth programs aimed at accelerating the interpretation of novel immunotherapies into scientific tria